Your browser doesn't support javascript.
loading
Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature.
Bellone, J; Ghizzoni, L; Aimaretti, G; Volta, C; Boghen, M F; Bernasconi, S; Ghigo, E.
Afiliação
  • Bellone J; Department of Clinical Pathophysiology, University of Turin, Italy.
Eur J Endocrinol ; 133(4): 425-9, 1995 Oct.
Article em En | MEDLINE | ID: mdl-7581965
Growth hormone-releasing peptide 6 (GHRP-6) is a synthetic hexapeptide with a potent GH-releasing activity after intravenous, subcutaneous, intranasal and oral administration in man. Previous data showed its activity also in some patients with GH deficiency. The aim of our study was to verify the GH-releasing activity of oral GHRP-6 administration on GH secretion in children with normal short stature. The effect of oral GHRP-6 (300 micrograms/kg) was compared with that of the maximally effective dose of intravenous GH-releasing hormone (GHRH-29, 1 microgram/kg). As the GHRH-induced GH rise in children is potentiated by arginine (ARG), even when administered by oral route at low dose (4 g), we studied also the interaction of oral GHRP-6 and ARG administration. We studied 13 children (nine boys and four girls aged 6.2-10.5 years, pubertal stage I) with normal short stature (height less than -2 SD score; height velocity more than -2 SD score; normal bone age; insulin-like growth factor I > 70 micrograms/l). In a first group of children (N = 7), oral GHRP-6 administration induced a GH response (mean +/- SEM; peak at 60 min vs baseline: 18.8 +/- 3.0 vs 1.1 +/- 0.3 micrograms/l, p < 0.0006; area under curve: 1527.3 +/- 263.9 micrograms l-1 h-1) which was similar to that elicited by GHRH (peak at 45 min vs baseline: 20.8 +/- 4.5 vs 2.2 +/- 0.9 micrograms/l, p < 0.007; area under curve: 1429.4 +/- 248.2 micrograms l-1 h-1).(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Hormônio do Crescimento / Transtornos do Crescimento Tipo de estudo: Clinical_trials Limite: Child / Female / Humans / Male Idioma: En Ano de publicação: 1995 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Hormônio do Crescimento / Transtornos do Crescimento Tipo de estudo: Clinical_trials Limite: Child / Female / Humans / Male Idioma: En Ano de publicação: 1995 Tipo de documento: Article